Physician profile
Jesse E Seidman
NPI 1356432066
$2,791.99
in general payments reported to CMS, 2019-2025
24 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $1,172 · 2021: $222 · 2022: $565 · 2023: $225 · 2024: $67.05 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.02 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,464.16 | 2019-2024 | Gmk Sphere |
| Arthrex, INC. | $184.95 | 2025 | |
| Carbofix Orthopedics INC | $168.30 | 2022 | |
| Ermi LLC | $122.21 | 2020-2025 | |
| Dynasplint Systems INC. | $118.82 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $113.99 | 2023 | Seglentis |
| Bioventus LLC | $73.45 | 2022-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Amniox Medical, INC. | $64.48 | 2019 | |
| Ferring Pharmaceuticals INC. | $62.96 | 2019-2021 | |
| Vericel Corporation | $48.51 | 2021 | |
| Encore Medical, Lp | $43.14 | 2020 | |
| Orthogenrx INC. | $38.51 | 2019-2020 | |
| Organogenesis INC. | $35.36 | 2021 | |
| Fidia Pharma USA INC. | $35.09 | 2022 | |
| Polynovo North America LLC | $26.61 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Moximed, INC | $26.23 | 2025 | Misha Knee System, Small, Left |
| Molnlycke Health Care US, LLC | $25.22 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Pacira Pharmaceuticals Incorporated | $25.21 | 2025 | Zilretta, Iovera |
| Trice Medical, INC. | $23.56 | 2019 | |
| United Orthopedics LLC | $23.30 | 2023 | |
| Boston Scientific Corporation | $22.54 | 2025 | Wavewriter Alpha Prime 16 |
| Baxter Healthcare | $18.21 | 2025 | Floseal |
| Avanos Medical | $17.55 | 2022 | |
| Orthofix Medical, INC. | $9.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Seidman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.